News

Share Print
Main content
Research news

Research on Alzheimer's disease and neurodegenerative diseases is steadily progressing. In this section you will find various news items that make up the current news in this field, in Switzerland and around the world.

Lecanemab effective against Alzheimer's disease - strong support for the toxic role of amyloid

The results of a global phase 3 clinical trial of lecanemab, a new treatment for Alzheimer's disease, have been published in a press release

Professor Jean-Marie Annoni retires

Professor Jean-Marie Annoni, co-chief physician of the Neurology Unit at the Fribourg Hospital, retired on 31 August 2022. .

The role of lipids in the development of Alzheimer’s disease

A European consortium coordinated by UNIGE shows how a mutation in the APOE protein changes the lipid transport in the brain and could promote the arise of Alzheimer’s disease.

 

The probabilistic model of Alzheimer disease: The amyloid hypothesis revised

A proposal for a probabilistic model, in which amyloid would remain a key player, but as one of several risk factors.

Blood biomarkers: a promising new avenue for large-scale screening for Alzheimer's disease

A recent study allowed researchers to assess the level of concordance between lumbar puncture, positron emission tomography and blood tests. 

CLAMP* project: acoustic and visual stimulation to reduce amyloid

The aim of the CLAMP project is to determine whether multisensory stimulation at 40 Hz can reduce the amount of amyloid in the brain of people who have high levels of this protein.

Dernière mise à jour : 11/08/2022